8/4/2020  4:43:42 PM Chg. -2.25 Volume Bid4:43:42 PM Ask4:43:47 PM Market Capitalization Dividend Y. P/E Ratio
66.55CHF -3.27% 229,521
Turnover: 12.32 mill.
66.50Bid Size: 1,384 66.55Ask Size: 708 3.34 bill.CHF 2.70% 26.26

Business description

Galenica AG is the leading fully integrated healthcare provider in Switzerland. With nearly 500 own, joint venture and independent partner pharmacies, Galenica operates the largest network of pharmacies in Switzerland. In addition, Galenica further develops and offers well-known own brands and prod-ucts, exclusive brands and products from business partners as well as a variety of on-site health services and tests for customers. Galenica is also the leading provider of pre-wholesale and whole-sale distribution as well as database services in the Swiss healthcare market.

Management board & Supervisory board

Marc Werner
Management board
Felix Burkhard, Christoph Amstutz, Daniele Madonna, Thomas Szuran
Supervisory board
Bertrand Jungo, Daniela Bosshardt, Dr. Andreas Walde, Dr. Markus R. Neuhaus, Dr. Philippe Nussbaumer, Pascale Bruderer, Prof. Dr. Michel Burnier

Company data

Name: Galenica AG
Address: Untermattweg 8,CH-3027 Bern
Phone: +41-58-8528111
Fax: +41-58-8528112
E-mail: info@galenica.com
Internet: www.galenica.com
Industry: Consumer Goods
Sector: Retailers
Sub sector: -
End of financial year: 12/31
Free Float: -
IPO date: 4/7/2017

Investor relations

Name: Felix Burkhard
IR phone: +41-58-8528529
IR Fax: +41-58-8528535
IR e-mail: investors@galenica.com

Company calendar

CW 32 | 8/4/2020 Interim Report 2nd Quarter/6 Months
CW 11 | 3/9/2021 4th Quarter/Annual Report
CW 20 | 5/12/2021 General Shareholder Meeting

Main Shareholders

UBS Fund Management (Switzerland) AG
BlackRock, Inc
Alecta pensionsförsäkring, Sweden
Credit Suisse Funds AG
Rudolf Maag, Binningen
The Capital Group Companies, Inc. - Capital Research and Management Company
Norges Bank (the Central Bank of Norway)
JPMorgan Chase & Co., New York, USA